Loading organizations...
§ Private Profile · Irvine, CA, USA
Medical device developer focused on continuous glucose monitoring and insulin delivery systems for diabetes management.
Founded in 2014 by Paul Strasma, Capillary Biomedical is an Irvine, California-based medical device company that develops continuous glucose monitoring and insulin delivery systems for patients and healthcare systems. The organization aims to simplify diabetes management by creating a fully implantable automated insulin delivery system that integrates a long-term glucose monitor, an insulin pump, and a closed-loop algorithm. Prior to its exit, the enterprise secured a total of $4.75 million in venture funding from notable investors including the Harvard Business School Alumni Angels Association and The Leona M and Harry B Helmsley Charitable Trust. The company also collaborated with the Jefferson Artificial Pancreas Center to advance its technologies designed to manage blood glucose automatically. Subsequently, Tandem Diabetes Care, a prior investor, officially acquired the business for an undisclosed amount on July 21, 2022.
Capillary Biomedical has raised $2.9M across 1 funding round.
Capillary Biomedical has raised $2.9M in total across 1 funding round.
Capillary Biomedical has raised $2.9M in total across 1 funding round.
Capillary Biomedical's investors include Cove Fund, ACE Fund, Go Philly Fund, Harvard Business School Alumni Angels of New York, Mass Medical Angels, New York Angels, Pasadena Angels, Tech Coast Angels.
Capillary Biomedical has raised $2.9M across 1 funding round. Most recently, it raised $2.9M Seed in August 2018.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 14, 2018 | $2.9M Seed | Cove Fund | ACE Fund, GO Philly Fund, Harvard Business School Alumni Angels OF NEW York, Mass Medical Angels, NEW York Angels, Pasadena Angels, Tech Coast Angels | Announced |